Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Safety of phosphatidylserine containing omega-3 fatty acids in non-demented elderly: a double-blind placebo-controlled trial followed by an open-label extension

  • Veronika Vakhapova1,
  • Yael Richter2,
  • Tzafra Cohen2,
  • Yael Herzog2 and
  • Amos D Korczyn3Email author
BMC Neurology201111:79

DOI: 10.1186/1471-2377-11-79

Received: 13 February 2011

Accepted: 28 June 2011

Published: 28 June 2011

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
13 Feb 2011 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
26 Feb 2011 Reviewed Reviewer Report - Jeffrey Lewis
2 Mar 2011 Reviewed Reviewer Report - Laszlo Vecsei
16 Mar 2011 Reviewed Reviewer Report - Edward Huey
27 Apr 2011 Author responded Author comments - Veronika Vakhapova
Resubmission - Version 3
27 Apr 2011 Submitted Manuscript version 3
23 May 2011 Author responded Author comments - Veronika Vakhapova
Resubmission - Version 4
23 May 2011 Submitted Manuscript version 4
Publishing
28 Jun 2011 Editorially accepted
28 Jun 2011 Article published 10.1186/1471-2377-11-79

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article.. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Neurology Department, Tel-Aviv Sourasky Medical Center
(2)
Enzymotec Ltd
(3)
Sieratzki Chair of Neurology, Tel-Aviv University Medical School

Advertisement